Get the latest news, insights, and market updates on PNTG (The Pennant Group, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
1 Russell 2000 Stock on Our Buy List and 2 We Ignore
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses. Jan 1, 2026 - $PNTG
Pennant Group (PNTG): Revisiting Valuation After a 3‑Year Turnaround and Recent Share Price Momentum
Pennant Group (PNTG) has quietly delivered a strong multi year turnaround, with the stock up about 195% over the past 3 years while continuing to grow revenue and profits in its post acute care niche. See our latest analysis for Pennant Group. Over the past year, Pennant Group’s modest 1 year total shareholder return of 9.36% contrasts with a much stronger 90 day share price return of 19.76%. This suggests momentum is picking up as investors warm to its improving fundamentals. If this... Dec 22, 2025 - $PNTG
1 Profitable Stock to Keep an Eye On and 2 We Question
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Dec 18, 2025 - $PNTG
Wasatch Micro-Cap Fund’s Updates on Pennant Group (PNTG)
Wasatch Global Investors, an asset management company, released its “Wasatch Micro-Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Microcap stocks reported strong results in the quarter, due to the consistent risk appetite of investors. The fund—Investor Class returned 9.52% in the quarter but lagged the benchmark Russell Microcap® […] Dec 18, 2025 - $PNTG
Pennant Group (PNTG): Assessing Valuation After Truist Upgrade and Easing 2026 Medicare Concerns
Pennant Group (PNTG) just got a confidence boost, with Truist Securities upgrading the stock after regulators outlined more forgiving 2026 Medicare home health rules and the market digested its large Amedisys acquisition integration. See our latest analysis for Pennant Group. Zooming out, Pennant’s momentum has picked up meaningfully, with a 30 day share price return of about 15 percent and a 90 day gain near 19 percent, even though the 12 month total shareholder return still sits slightly... Dec 5, 2025 - $PNTG
The Bull Case For Pennant Group (PNTG) Could Change Following Truist Upgrade And Medicare Rule Shift
Recently, Truist Securities upgraded The Pennant Group to a “buy” rating, highlighting improving operating trends, strong demand for senior care, and reduced reimbursement risk following a more favorable 2026 Medicare home health rule. This shift in analyst sentiment, combined with smoother-than-expected integration of newly acquired Amedisys locations, points to potentially stronger operational resilience for Pennant’s home health and senior living platform. With Truist highlighting reduced... Dec 4, 2025 - $PNTG
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.